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Virales” and 6) Equipe Biostatistiques, LERTIM, Faculté de Médecine, Marseille, FranceAbstractEvery year, more than 10 million pilgrims arrive in the Kingdom of Saudi Arabia for the Hajj or Umrah. Crowding conditions lead to high rates
of respiratory infections among the pilgrims, representing a signiﬁcant cause of morbidity and a major cause of hospitalization. Pre- and post-
Hajj nasal specimens were prospectively obtained from a paired cohort (692 pilgrims) and from nonpaired cohorts (514 arriving and 470
departing pilgrims) from 13 countries. The countries of residence included Africa (44.2%), Asia (40.2%), the United States (8.4%) and
Europe (7.2%). Nasal specimens were tested for 34 respiratory pathogens using RT-PCR. A total of 80 512 PCRs were performed. The
prevalence of viruses and bacteria increased, from 7.4% and 15.4% before the Hajj to 45.4% and 31.0% after the Hajj, respectively, due to
the acquisition of rhinovirus, coronaviruses (229E, HKU1, OC43), inﬂuenza A H1N1, Streptococcus pneumoniae, Haemophilus inﬂuenzae
and Staphylococcus aureus. We did not identify Middle East respiratory coronavirus carriage. At arrival, the prevalence of several viruses
was clearly dependent on the pilgrim’s country of origin. After Hajj participation, these viruses were isolated among pilgrims from all
countries, with few exceptions. No signiﬁcant differences were observed between paired and nonpaired cohort results. Our results
strongly suggest that, given the particularly crowded conditions during the rituals, an international mass gathering such as the Hajj may
contribute to the globalization of respiratory pathogens after the cross-contamination of pilgrims harbouring pathogens that easily spread
among participants. Inﬂuenza and pneumococcal vaccination, face mask use and hand hygiene should be considered in the context of the Hajj.
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E-mail: philippe.gautret@club-internet.frIntroductionEvery year, more than 10 million pilgrims from over 180
countries arrive at Makkah for the Hajj or Umrah. The number
of pilgrims undertaking the Hajj has increased by a factor 5 fromClinical Microbiology and Infection © 2015 European Society of C1920 to 2012 [1]. One of the major public health concerns in
relation to mass gatherings is the importation or exportation of
infectious diseases, spread between attendees and the local
population and further spread to home countries through the
returning participants [2]. The crowding conditions within a
conﬁned area during the Hajj leads to high rates of upper and
lower respiratory infections among the pilgrims, which repre-
sent a signiﬁcant cause of morbidity and a major cause of
hospitalization [3]. Recent studies conducted among French
pilgrims showed rapid acquisition of respiratory viruses and
bacteria carriage, particularly rhinovirus and StreptococcusClin Microbiol Infect 2015; 21: 571.e1–571.e8
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
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nasal carriage of a large panel of 34 respiratory pathogens
among pilgrims arriving in the Kingdom of Saudi Arabia (KSA)
from 13 countries on four continents and among pilgrims
departing from KSA after participating in the Hajj. The aim of
the study was to identify changes in colonization before and
after the pilgrimage and to investigate circulation and potential
for globalization of these pathogens using two distinct cohort
survey designs based on previous works [4–9].MethodsParticipants and study design
Pilgrims participating in the 2013 Hajj were recruited upon
arrival at the Jeddah airport (October 2 to October 7) and after
performing the Hajj, at the Mina encampment before leaving the
KSA (October 16 to October 24). The selection of the country
of residence was based on representative countries from each
continent and the availability of nationalities during the sampling
dates. Potential adult participants were asked to participate in
the study on a voluntary basis. Three groups of pilgrims were
investigated. One group was included in a paired cohort survey
in which the same pilgrims were evaluated before and after
participating in the Hajj. The two other groups were included in
a nonpaired cohort survey: one group consisted of pilgrims
recruited before the Hajj, and the other consisted of different
pilgrims of the same nationalities recruited after the Hajj.
Upon inclusion, the participants were interviewed by in-
vestigators using a standardized questionnaire that collected
information on demographics, vaccination status and medical
history. A post-Hajj questionnaire that collected clinical data and
information on compliance with face mask use was completed by
the same team of investigators. The protocol was approved by
the Saudi Ministry of Health ethical review committee. The study
was performed in accordance with the good clinical practices
recommended by the Declaration of Helsinki and its amend-
ments. All participants provided oral informed consent.
Respiratory specimens
Nasal swabs were collected at arrival and at Mina from each
participant (anterior nares) using commercial rigid cotton-
tipped swab applicators (Remel, USA), placed in universal
transport medium (Remel) at the time of collection and stored
in a freezer at −80°C within 48 hours of collection. The
specimens were transported on dry ice to France for analysis.
Each swab was processed manually. One milliliter of medium
was pipetted automatically (Beckman NX automate) to prepare
96-well microplates for total (DNA + RNA) nucleic acid
extraction and long-term storage. To avoid unnecessary testing,Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infecta dual aliquot was prepared from 100 μL of nasal swab origin.
The total nucleic acids were then puriﬁed using the Macherey-
Nagel Nucleospin-96 kit. The extract was then split for testing
for the presence of viruses and bacteria.
Detection of respiratory viruses
The real-time PCR detection of viruses was performed (a) using
the FTD Respiratory Pathogens 21-plus kit (Fast Track Di-
agnostics, Luxembourg) for inﬂuenza A (FLUA)/H3N2, 2009
FLUA/H1N1 (A/H1N1), inﬂuenza B (FLUB), human rhinovirus
(HRV), human coronavirus (HCoV) NL63, 229E, OC43, HKU1,
human parainﬂuenza virus (HPIV) 1 through 4, human meta-
pneumovirus A/B (HMPV), human bocavirus, human respira-
tory syncytial virus A/B (HRSV), human adenovirus (HAdV),
human enterovirus from all groups (HEV) and parechovirus
(HPeV), and (b) using single-plex assays for Middle East respi-
ratory coronavirus [10,11], human cytomegalovirus [12] and
inﬂuenza C virus [13], with internal controls as described [14].
Detection of respiratory bacteria and Pneumocystis
jirovecii
All real-time PCRs were performed using a 7900HT-thermo-
cycler (Applied Biosystems, USA) and QuantiTect-Probe PCR
Kit (Qiagen, France) according to the manufacturer’s recom-
mendations. Each sample was tested for Streptococcus pneumo-
niae, Haemophilus inﬂuenzae, Klebsiella pneumoniae,
Staphylococcus aureus, Neisseria meningitidis, Coxiella burnetii,
Bordetella pertussis, Mycoplasma pneumoniae, Legionella pneumo-
phila, Streptococcus pyogenes, Salmonella spp., Pneumocystis jir-
ovecii and Chlamydia pneumoniae with the primers and probes
listed in Supplementary Table S1. A negative control (sterile
water) and positive control (DNA from the bacterial strain)
were included in each run.
Statistical analysis
Differences in the proportions were tested by Pearson’s chi-
square, McNemar’s chi-square or Fisher’s exact tests when
appropriate. All statistical tests were two-sided. Percentages
and odds ratio (OR) with 95% conﬁdence interval (CI) esti-
mations and comparisons were carried out using the R 2.8.1
environment (The R Foundation for Statistical Computing,
Austria; http://www.r-project.org). A p value of 0.05 was
considered signiﬁcant.ResultsCharacteristics of the study participants
A total of 1206 individuals were recruited at arrival to partic-
ipate in the study, and all responded to the pretravelious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 571.e1–571.e8
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included in the paired cohort survey, and 514 individuals were
included in the nonpaired cohort survey (arrival group). A total
of 470 additional individuals were included in the nonpaired
cohort survey after the Hajj (departure group). Overall, the M/F
sex ratio was 1.9, with a mean age of 50 years (age range,
18–88 years). The countries of residence included Africa
(44.2%), Asia (40.2%), the United States (8.4%) and Europe
(7.2%). Documentation about chronic conditions was missing in
most cases. Among the individuals for whom information was
available, 21.9% declared having been vaccinated against inﬂu-
enza in 2013 and 1.2% against invasive pneumococcal diseases
during the 5 past years. Of 1162 pilgrims investigated after the
Hajj, 61.9% reported inﬂuenza-like illness, and 45.5% took
antibiotics.
Overall detection of respiratory pathogens
A total of 80 512 PCRs were performed (Table 1). Overall, the
prevalence of viruses increased from 7.4% of the pre-Hajj
specimens to 45.4% of the post-Hajj specimens testingTABLE 1. Overall prevalence of respiratory viruses, bacteria and P
Respiratory pathogen
Paired cohort
Arrival, n (%)
of positive
specimens
Departure, n (%)
of positive
specimens p
A
sp
in
Viruses
Inﬂuenza virus A/H3N2 4 (0.6%) 14 (2.0%) 0.71 13
Inﬂuenza virus 2009 A(H1N1) 1 (0.1%) 11 (1.6%) 0.32 10
Inﬂuenza virus B 0 0 — 0
Inﬂuenza virus C 0 0 — 0
Human parainﬂuenza viruses 1 0 0 — 0
Human parainﬂuenza viruses 2 0 2 (0.3%) — 2
Human parainﬂuenza viruses 3 2 (0.3%) 1 (0.1%) — 1
Human parainﬂuenza viruses 4 0 1 (0.1%) — 1
MERS coronavirus 0 0 — 0
Human coronavirus 229E 6 (0.9%) 101 (14.6%) <0.001 10
Human coronavirus NL63 2 (0.3%) 14 (2.0%) 0.71 13
Human coronavirus HKU1 3 (0.4%) 9 (1.3%) 0.16 9
Human coronavirus OC43 1 (0.1%) 11 (1.6%) 0.34 11
Human cytomegalovirus 0 0 — 0
Human enterovirus 4 (0.6%) 3 (0.4%) — 3
Human metapneumovirus 0 1 (0.1%) — 1
Human respiratory syncytial virus 4 (0.6%) 5 (0.7%) — 5
Human rhinovirus 15 (2.2%) 238 (34.4%) <0.001 23
Human adenovirus 0 4 (0.6%) — 4
Human bocavirus 1 (0.1%) 0 — 0
Parechovirus 0 1 (0.1%) — 1
At least one virus 42 (6.1%) 343 (49.6%) <0.001 34
Bacteria
Bordetella pertussis 0 0 — 0
Mycoplasma pneumoniae 0 0 — 0
Neisseria meningitidis 0 2 (0.3%) — 2
Streptococcus pneumoniae 39 (5.6%) 88 (12.7%) <0.001 83
Streptococcus pyogenes 0 0 — 0
Klebsiella pneumoniae 20 (2.9%) 27 (3.9%) 0.09 27
Legionella pneumophila 0 0 — 0
Salmonella spp. 0 0 — 0
Staphylococcus aureus 39 (5.6%) 55 (7.9%) <0.001 52
Coxiella burnetii 0 1 (0.1%) — 1
Chlamydophila pneumoniae 0 0 — 0
Haemophilus inﬂuenzae 16 (2.3%) 81 (11.7%) <0.001 79
At least one bacteria 101 (14.6%) 201 (29.0%) <0.001 19
Pneumocystis jirovecii 0 0 — 0
At least one pathogen 136 (19.7%) 430 (62.1%) <0.001 42
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inpositive for at least one virus. This increase was statistically
signiﬁcant for HRV and HCoV 229E in both cohorts and for
FLUA H1N1, HCoV HKU1 and OC43 in the nonpaired cohort
survey. The overall acquisition rate calculated from the paired
cohort was 49.1% (34.1% and 14.6%, respectively, for HRV and
HCoV 229E). FLUA, FLUB, HCoV NL63, HPIV 2, 3 and 4, HEV,
HMPV, HRSV, HAdV and HPeV were also acquired during the
stay in KSA by a low proportion of the participants. None of
the participants tested positive for inﬂuenza C virus, Middle
East respiratory coronavirus or cytomegalovirus at any point
during the study period.
Overall, the prevalence of bacteria increased from 15.4% of
the pre-Hajj specimens to 31.0% of the post-Hajj specimens
testing positive for at least one bacterial pathogen. The increase
was statistically signiﬁcant for S. pneumoniae, H. inﬂuenzae and
S. aureus in both cohorts. The overall acquisition rate calculated
from the paired cohort was 28.3% for bacteria (12.0%, 11.4%
and 7.5%, respectively, for S. pneumoniae, H. inﬂuenzae and
S. aureus). K. pneumoniae, N. meningitidis and C. burnetii were
also acquired during the stay in KSA by a low proportion of theneumocystis jirovecii among participants
Nonpaired cohort
cquisition rate, n (%) positive
ecimens at departure among
dividuals negative at arrival
Arrival, n (%)
of positive
specimens
Departure, n (%)
of positive
specimens p
(1.9%) 6 (1.2%) 8 (1.7%) 0.48
(1.4%) 1 (0.2%) 14 (3.0%) <0.001
0 1 (0.2%) 0.48
0 0 —
2 (0.4%) 0 0.50
(0.3%) 1 (0.2%) 2 (0.4%) 0.61
(0.1%) 0 1 (0.2%) 0.61
(0.1%) 1 (0.2%) 0 1
0 0 —
1 (14.6%) 5 (1.0%) 48 (10.2%) <0.001
(1.9%) 0 1 (0.2%) 0.48
(1.3%) 1 (0.2%) 7 (1.5%) 0.03
(1.6%) 2 (0.4%) 9 (1.9%) 0.02
0 0 —
(0.4%) 4 (0.8%) 5 (1.1%) 0.74
(0.1%) 1 (0.2%) 3 (0.6%) 0.35
(0.7%) 3 (0.6%) 1 (0.2%) 0.63
6 (34.1%) 16 (3.1%) 145 (30.9%) <0.001
(0.6%) 0 2 (0.4%) 0.23
1 (0.2%) 0 1
(0.1%) 0 0 —
0 (49.1%) 44 (8.6%) 212 (45.1%) <0.001
0 0 —
0 0 —
(0.3%) 0 3 (0.6%) 0.11
(12.0%) 24 (4.7%) 64 (13.6%) <0.001
0 0 —
(3.9%) 24 (4.7%) 26 (5.5%) 0.54
0 0 —
0 0 —
(7.5%) 32 (6.2%) 46 (9.8%) 0.04
(0.1%) 0 0 —
0 0 —
(11.4%) 12 (2.3%) 67 (14.3%) <0.001
6 (28.3%) 83 (16.1%) 158 (33.6%) <0.001
0 0 —
5 (61.4%) 121 (23.5%) 306 (65.1%) <0.001
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tive for B. pertussis, M. pneumoniae, S. pyogenes, L. pneumophila,
Salmonella spp., C. pneumoniae or P. jirovecii at any point during
the study period.
Multiple carriage was common, accounting for 40% of the
positive post-Hajj specimens (two pathogens, 29.3%; three
pathogens, 9.0%; four pathogens, 1.6%; ﬁve pathogens, 0.1%).
The most frequent associations were HRV/H. inﬂuenzae, fol-
lowed by HRV/S. pneumoniae, S. pneumoniae/H. inﬂuenzae, HRV/
HCov 229E and HRV/S. aureus (Supplementary Fig. S1).
Detection of respiratory pathogens by country of
residence
At arrival, the prevalence of several viruses was clearly
dependent on the pilgrim’s country of origin (Figs. 1 and 2).
H1N1 was found only among pilgrims arriving from Indonesia.
HCoVs were isolated among pilgrims arriving from Africa and
Southeast Asia only, with the exception of HCoV HKU1, which
was also isolated among pilgrims from Albania. In contrast, HRV
and FLUA/H3N2, to a lesser extent, and several bacteria
including S. pneumoniae, H. inﬂuenzae, K. pneumoniae and
S. aureus were found in pilgrims arriving from a wide range of
regions.FIG. 1. Nasal carriage prevalence of 34 respiratory pathogens among a paired
in the 2013 Hajj.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectAfter participation in the Hajj, these viruses and bacteria
were isolated among pilgrims from all countries, with few ex-
ceptions. The acquisition rate of HRV calculated from the
paired cohort was signiﬁcantly higher among the pilgrims from
Indonesia (OR 3.6, CI 1.32–7.93, p 0.01) and Bangladesh (OR
2.67, CI 1.01–7.32, p 0.05) compared to the pilgrims from the
United States. The acquisition rate of H. inﬂuenzae was also
higher among the pilgrims from Indonesia (OR 23.4, CI
4.31–438, p 0.003).
Other factors
The effects of age, sex, chronic conditions, vaccination status,
face mask use, occurrence of inﬂuenza-like illness symptoms
and antibiotic use on the acquisition rate of the pathogens most
frequently isolated was investigated in the paired cohort. We
found that age was associated with the acquisition of HCoV
NL63 (OR 1.2 by year of age, CI 1.04–1.33, p 0.02) and S.
pneumoniae (OR 1.03 by year of age, CI 1.002–1.06, p 0.04) and
that diabetes was associated with the acquisition of HCoV
NL63 (OR 29.2, CI 1–837, p 0.04) and H. inﬂuenzae (OR 3.6,
CI 1.16–11.2, p 0.025).
From the nonpaired cohort, we found a signiﬁcant negative
association between K. pneumoniae carriage and the occurrencecohort of 692 pilgrims from 11 countries before and after participating
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 571.e1–571.e8
FIG. 2. Nasal carriage prevalence of 34 respiratory pathogens between two distinct groups of pilgrims from 13 countries sampled before (n = 514) and
after (n = 470) participating in the 2013 Hajj (nonpaired cohort survey).
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0.11, CI 0.01–0.63, p 0.03).DiscussionWe found that the mass gathering of the Hajj pilgrimage is
associated with the nasal acquisition of respiratory pathogens in
more than 60% of the pilgrims. In this multinational survey, we
conﬁrm our previous observations made among French pil-
grims that HRV, non-Middle East respiratory coronaviruses,
FLUA viruses and S. pneumoniae account for the majority of
pathogens acquired by pilgrims [4–7]. Additionally, we
demonstrate that H. inﬂuenzae and S. aureus are also among the
most frequent pathogens for which nasal carriage is increased
after participation in the Hajj. These pathogens may be intro-
duced into the pilgrims’ home countries upon their return, thus
contributing to their potential international spread. We did not
identify Middle East respiratory coronavirus carriage, conﬁrm-
ing previous research [6,9,15,16].
We provide for the ﬁrst time a global picture of the circu-
lation of respiratory pathogens at the Hajj. We observed threeClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Indistinct epidemiological patterns. The ﬁrst pattern was char-
acterized by the introduction into KSA of pathogens isolated at
low rates among pilgrims arriving speciﬁcally from one or two
countries (Fig. 3 and Supplementary Fig. S2). Some of these
pathogens then spread to pilgrims from a large number of
countries, with a slight increase in overall prevalence. This was
particularly obvious for A/H1N1, which was found in two In-
donesians only upon arrival but spread to 25 pilgrims from
Africa, Central Asia and Southeast Asia after the Hajj. A survey
conducted in a separate and larger paired cohort of French
pilgrims at the same period also showed the acquisition of A/
H1N1 after the Hajj, whereas the pilgrims sampled before
leaving France were negative [7]. This indicates that the
acquisition resulted not only from human-to-human trans-
mission through close contact within each group of pilgrims
from the same country but was also acquired from other pil-
grims, given the extremely high crowding density to which in-
dividuals from many parts of the world are exposed when
performing Hajj rituals. Contamination originating from an
environmental source may also have played a role.
Other viruses were speciﬁcally isolated among rare pilgrims
from one or two countries, but their spread was more limitedfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 571.e1–571.e8
FIG. 3. Nasal carriage of A/H1N1 virus and human parainﬂuenza virus 1, 2 and 4 among pilgrims arriving in the KSA (n = 1206) and departing from the
KSA from (n = 1162) after participating in the 2013 Hajj and according to country of residence.
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ologic pattern was that of cosmopolitan pathogens (Fig. 4 and
Supplementary Figs. S3 and S4), including HRV, S. pneumoniae,
H. inﬂuenzae, K. pneumoniae and S. aureus. These pathogens
were isolated in 2% to 6% of the pilgrims arriving from almost
all countries, with further ampliﬁcation among the entire pop-
ulation of pilgrims after the Hajj in an epidemic mode, with
acquisition rates of 11% to 34%. Some viruses such as HRV
appeared to be spread among a very high proportion of pil-
grims, as exempliﬁed by the Bengali pilgrims, who were all
negative at arrival but presented a prevalence of 50% after the
Hajj. FLUA/H3N2, HCoVs, HEV and HRSV showed comparable
patterns of transmission, but their geographical spread and/or
prevalence were lower. Finally, a third pattern was observed,
whereby pathogens were sporadically isolated among departing
pilgrims but were never isolated among arriving ones (Fig. 5 and
Supplementary Fig. S2). This group included FLUB, HAdV,
HPeV N. meningitidis and C. burnetii. This pattern may be
explained by an overall low prevalence of pathogens among
adults worldwide (FLUB) [17] or by a preferential circulation of
pathogens in KSA (C. burnetii) [18].
The purpose of this work was not to demonstrate whether
the pathogens detected in the respiratory specimens were
responsible for the observed symptoms. Nasal carriage wasClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectobserved in asymptomatic pilgrims in certain cases. Further-
more, swabs were taken from the anterior nose and may thus
be more representative of colonization than acute infection.
Nevertheless, we postulate that “Hajj cough” may result from
infection of the respiratory tract by various respiratory viruses,
notably including HRV and HCoV229E, which are known to
cause mild or serious lower respiratory tract infections [19,20].
The results obtained from the paired and nonpaired cohort
led to similar conclusions. The paired cohort survey design,
however, allows the calculation of the acquisition rates of
pathogens, whereas the nonpaired cohort survey only allows for
comparing the prevalence of pathogens at arrival and departure.
We found that the nonpaired cohort survey results slightly
underestimated the increase in the prevalence of viruses after
participation in the Hajj compared to the paired cohort survey
results. This discrepancy was not observed for bacterial carriage.
Among the pathogens most frequently acquired by pilgrims,
three account for vaccine-preventable diseases, including inﬂu-
enza, S. pneumoniae and H. inﬂuenzae infections. Thus, the
availability of the seasonal inﬂuenza vaccine to all target in-
dividuals attending the Hajj should be highlighted [21,22].
Additionally, vaccination with a conjugate pneumococcal vaccine
should be considered in individuals with medical risk factors for
invasive pneumococcal disease [23]. Studies are needed toious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 571.e1–571.e8
FIG. 4. Nasal carriage of human rhinovirus, Streptococcus pneumoniae, Haemophilus inﬂuenzae and Klebsiella pneumoniae among pilgrims arriving in the
KSA (n = 1206) and pilgrims departing from the KSA (n = 1162) after participating in the 2013 Hajj and according to country of residence.
FIG. 5. Nasal carriage of inﬂuenza B virus, human adenovirus, Neisseria meningitidis and Coxiella burnetii among pilgrims arriving in the KSA (n = 1206)
and pilgrims departing from the KSA (n = 1162) after participating in the 2013 Hajj and according to country of residence.
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context of the Hajj. Nonpharmaceutical intervention including
face mask use and hand hygiene should be also considered [24].
Our study has some limitations. The included population
represented only a small percentage of the total number of
pilgrims attending the 2013 Hajj; hence, the results cannot be
extrapolated to the entire pilgrim population. The number of
pilgrims from Europe and the United States was limited, and no
pilgrims from the Middle East were included. In addition, data
on chronic health conditions, preventive measures and symp-
toms during the Hajj were difﬁcult to obtain and were available
only for a limited number of subjects. Nevertheless, our study
investigated a much larger and geographically more diverse
cohort than previous studies [4–7]. Overall, these results
strongly suggest that, given the particularly crowded conditions
during the rituals, an international mass gathering such as the
Hajj may contribute to the globalization of common respiratory
pathogens after the cross-contamination of pilgrims harbouring
pathogens that easily spread among participants [25].Transparency declarationAll authors report no conﬂicts of interest relevant to this
article.Appendix A. Supplementary dataSupplementary data related to this article can be found at http://
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